New Investor Trio Leads $12M Series B Financing for Coferon
July 18, 2012- Share:
New York-based biotechnology company Coferon has closed on $12 million of Series B financing led by new investors Hatteras Venture Partners, MedImmune Ventures and Ascent Biomedical Ventures. Currently, Coferon is conducting research and development of epignetics and anti-infectives.
- Share:
-
-
-
-